Hot topics in ischaemic heart disease: revascularization, hibernation, type 2 infarction, and proteomics.
- Published in:
- European Heart Journal, 2022, v. 43, n. 2, p. 89, doi. 10.1093/eurheartj/ehab902
- By:
- Publication type:
- Article
Works matching IS 0195668X AND DT 2022 AND VI 43 AND IP 2
Results: 16
1
2
new biomarker of acute coronary ischaemia: from bench to bedside?
- Published in:
- European Heart Journal, 2022, v. 43, n. 2, p. 164, doi. 10.1093/eurheartj/ehab776
- By:
- Publication type:
- Article
3
Computed tomography coronary angiography in acute chest pain: an excellent diagnostic tool with poor added value on clinical outcomes.
- Published in:
- European Heart Journal, 2022, v. 43, n. 2, p. 103, doi. 10.1093/eurheartj/ehab766
- By:
- Publication type:
- Article
4
Myocardial viability testing: all STICHed up, or about to be REVIVED?
- Published in:
- European Heart Journal, 2022, v. 43, n. 2, p. 118, doi. 10.1093/eurheartj/ehab729
- By:
- Publication type:
- Article
5
Risk factors for type 2 MI: the usual suspects or guilt by association?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
6
Glycosylated apolipoprotein J in cardiac ischaemia: molecular processing and circulating levels in patients with acute ischaemic events.
- Published in:
- European Heart Journal, 2022, v. 43, n. 2, p. 153, doi. 10.1093/eurheartj/ehab691
- By:
- Publication type:
- Article
7
Emergency treatment of a giant coronary aneurysm: percutaneous intervention with coronary and peripheral tools.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
8
How cardiac magnetic resonance is changing cardiovascular medicine: Mark Nicholls speaks to EuroCMR2021 Programme chair Professor Robert Manka about the conference highlights and what the future holds for cardiac magnetic resonance (CMR) imaging.
- Published in:
- European Heart Journal, 2022, v. 43, n. 2, p. 98, doi. 10.1093/eurheartj/ehab328
- By:
- Publication type:
- Article
9
Recognition for heart failure breakthrough.
- Published in:
- European Heart Journal, 2022, v. 43, n. 2, p. 93, doi. 10.1093/eurheartj/ehab321
- By:
- Publication type:
- Article
10
First and recurrent events in the ISCHEMIA trial: two sides of the same coin.
- Published in:
- European Heart Journal, 2022, v. 43, n. 2, p. 150, doi. 10.1093/eurheartj/ehab603
- By:
- Publication type:
- Article
11
Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 2, p. 148, doi. 10.1093/eurheartj/ehab509
- By:
- Publication type:
- Article
12
What's your gut telling you? How researchers are investigating the link between myocarditis and intestinal microbiota.
- Published in:
- European Heart Journal, 2022, v. 43, n. 2, p. 100, doi. 10.1093/eurheartj/ehab396
- By:
- Publication type:
- Article
13
Small blebs, big potential — can extracellular vesicles cure cardiovascular disease?
- Published in:
- European Heart Journal, 2022, v. 43, n. 2, p. 95, doi. 10.1093/eurheartj/ehab334
- By:
- Publication type:
- Article
14
Risk factors for type 1 and type 2 myocardial infarction.
- Published in:
- European Heart Journal, 2022, v. 43, n. 2, p. 127, doi. 10.1093/eurheartj/ehab581
- By:
- Publication type:
- Article
15
Invasive and non-invasive assessment of ischaemia in chronic coronary syndromes: translating pathophysiology to clinical practice.
- Published in:
- European Heart Journal, 2022, v. 43, n. 2, p. 105, doi. 10.1093/eurheartj/ehab548
- By:
- Publication type:
- Article
16
Fibroelastoma presenting with recurrent myocardial infarction and diagnosed with intracoronary imaging: a novel intracoronary image of fibroelastoma.
- Published in:
- 2022
- By:
- Publication type:
- Case Study